RAAS polymorphisms alter the acute blood pressure response to aerobic exercise among men with hypertension

被引:53
作者
Blanchard, BE [1 ]
Tsongalis, GJ
Guidry, MA
LaBelle, LA
Poulin, M
Taylor, AL
Maresh, CM
Devaney, J
Thompson, PD
Pescatello, LS
机构
[1] Univ Connecticut, Storrs, CT 06269 USA
[2] Hartford Hosp, Hartford, CT 06102 USA
[3] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[4] Childrens Natl Med Ctr, Washington, DC 20010 USA
关键词
genetics; postexercise hypotension; cycle exercise; ambulatory blood pressure;
D O I
10.1007/s00421-006-0142-8
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Limited evidence suggests renin-angiotensin-aldosterone system (RAAS) polymorphisms alter the blood pressure (BP) response to aerobic exercise training. We examined if RAAS polymorphisms influenced postexercise hypotension in men with high normal to Stage 1 hypertension. Forty-seven men (44.2 +/- 1.4 years, 145.1 +/- 1.6/85.5 +/- 1.1 mmHg) randomly completed three experiments: seated rest (control) and two cycle exercise bouts at 40% (LITE) and 60% (MOD) of maximal oxygen consumption. Ambulating BP was measured for 14 h after each experiment. RAAS polymorphisms associated with hypertension (i.e. angiotensin converting I enzyme, ACE I/D; angiotensin II type 1 receptor, AT(1)R A/C; and intron 2 of aldosterone synthase, Int2 W/C) were analyzed using polymerase chain reaction and restriction enzyme digestion. Repeated measure ANOVA tested if BP differed between experimental conditions by RAAS genotypes. Compared to men with 0-2 variant alleles, men with >= 3 combined RAAS variant alleles had lower average systolic BP (SBP) (P=0.030) and lower average diastolic BP (DBP) (P=0.009) for 14 h only after LITE. In contrast, average BP was not different for MOD and control between RAAS variant allele groups over this time period (P >= 0.05). LITE reduced BP in men with >= 3 variant RAAS alleles for 14 h, whereas MOD had no influence on BP in these men. In order to optimally prescribe exercise for its BP lowering benefits in those with hypertension, additional knowledge of how genetic variation affects the BP response to exercise is needed.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 28 条
[1]  
American College of Sports Medicine, 2000, ACSMS GUID EX TEST P
[2]  
Berge KE, 1998, CLIN GENET, V53, P214
[3]   Genetic polymorphism of the renin-angiotensin aldosterone system and arterial hypertension in the Italian population:: the GENIPER Project [J].
Castellano, M ;
Glorioso, N ;
Cusi, D ;
Sarzani, R ;
Fabris, B ;
Opocher, G ;
Zoccali, C ;
Golin, R ;
Veglio, F ;
Volpe, M ;
Mantero, F ;
Fallo, F ;
Rossi, GP ;
Barlassina, C ;
Tizzoni, L ;
Filigheddu, F ;
Giacchè, M ;
Rossi, F .
JOURNAL OF HYPERTENSION, 2003, 21 (10) :1853-1860
[4]   Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism [J].
Danser, AHJ ;
Deinum, J ;
Osterop, APRM ;
Admiraal, PJJ ;
Schalekamp, MADH .
JOURNAL OF HYPERTENSION, 1999, 17 (12) :1867-1872
[5]   The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives [J].
Díez, J ;
Laviades, C ;
Orbe, J ;
Zalba, G ;
López, B ;
González, A ;
Mayor, G ;
Páramo, JA ;
Beloqui, O .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :2085-2092
[6]   Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males [J].
Fornage, M ;
Amos, CI ;
Kardia, S ;
Sing, CF ;
Turner, ST ;
Boerwinkle, E .
CIRCULATION, 1998, 97 (18) :1773-1779
[7]   Exercise training-induced blood pressure and plasma lipid improvements in hypertensives may be genotype dependent [J].
Haberg, JM ;
Ferrell, RE ;
Dengel, DR ;
Wilund, KR .
HYPERTENSION, 1999, 34 (01) :18-23
[8]   Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population:: first results of the Hippocates study [J].
Henskens, LH ;
Spiering, W ;
Stoffers, HE ;
Soomers, FL ;
Vlietinck, RF ;
de Leeuw, PW ;
Kroon, AA .
JOURNAL OF HYPERTENSION, 2003, 21 (01) :81-86
[9]   Pharmacogenetics and cardiovascular disease: Impact on drug response and applications to disease management [J].
Humma, LM ;
Terra, SG .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (13) :1241-1252
[10]   Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway [J].
Kijima, K ;
Matsubara, H ;
Murasawa, S ;
Maruyama, K ;
Ohkubo, N ;
Mori, Y ;
Inada, M .
HYPERTENSION, 1996, 27 (03) :529-534